Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them. More
This technology is related to optimal conditions for culturing stem cells and feeder cells More
Scientists have developed novel biomaterials comprising of modified hydroxyapatite (HA) which can be used to improve bone, dental and oral health products as well as implant anchoring into the body. More
Novel methods of cell culture for production of human parvovirus B19 (B19). These specific cell lines demonstrate limited infectability and commonly produce little or no virus following initial inoculation with B19. More
Growing mesenchymal stem cells that retain their undifferentiated properties More
This invention relates to a cell based therapy; specifically, the isolation and enrichment of stem cells from adult tendons that can form tendon structures and are capable of integrating into bones to form enthesis-like structures. More
A method of providing a therapeutic effect in human patients by administering to the patient CD34+ cells obtained from umbilical cord blood. More
Methods for improving pancreatic endocrine function and delaying the onset of diabetes by enhancing beta cell function using ligands and/or regulators of Notch receptors More
Ready to use portfolio of BRCA2 mutant cell lines to study BRCA2 mutant functional analysis More
We have developed a methodology for a chemically defined and effcient protocol which targets human embryonic stem cells towards a chondroprogenitor phenotype. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2011 - 61 pages - $3,800
Mar 2008 - 250 pages - $3,995
Jan 2012 - 26 pages - $250
Nov 2010 - 7 pages - $500
May 2011 - 25 pages - $250
May 2011 - 15 pages - $250
Feb 2008 - 150 pages - $2,500
Mar 2006 - 207 pages - $2,875
Jun 2011 - 113 pages - $3,835
Nov 2009 - 229 pages - $4,650
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us